US FDA allows marketing of Zyn nicotine pouches and flavours other than tobacco

The US Food and Drug Administration (FDA) has authorised the marketing of 20 Zyn nicotine pouch products, marking the first time the agency has approved such products through its rigorous premarket tobacco product application (PMTA) process.

This landmark decision includes flavoured options beyond tobacco, mint, and menthol – such as chill, cinnamon, citrus, and coffee – and allows for two nicotine strengths (3 mg and 6 mg).

Read full article
I'm already a subscriber

Antonia Di Lorenzo

Assistant news editor/senior reporter
Antonia is a member of the editorial team and holds a masters degree in Law from the University of Naples Federico II, Italy. She moved in 2013 to London, where she completed a postgraduate course at the London School of Journalism. In the UK, she worked as a news reporter for a financial newswire and a magazine before moving to Barcelona in 2019.

Our Key Benefits

The global novel nicotine market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

TobaccoIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organisation